Cabot (NYSE:CBT) Updates FY25 Earnings Guidance

Cabot (NYSE:CBT) issued an update on its FY25 earnings guidance on Monday morning. The company provided EPS guidance of $7.40-7.80 for the period, compared to the consensus EPS estimate of $7.85. Cabot also updated its FY 2025 guidance to 7.400-7.800 EPS.

Cabot Trading Down 0.1 %

NYSE:CBT traded down $0.15 on Thursday, hitting $116.85. The stock had a trading volume of 289,331 shares, compared to its average volume of 339,714. The company has a fifty day moving average price of $108.69 and a two-hundred day moving average price of $101.24. Cabot has a 1-year low of $70.62 and a 1-year high of $117.46. The company has a quick ratio of 1.45, a current ratio of 2.22 and a debt-to-equity ratio of 0.72. The stock has a market cap of $6.41 billion, a price-to-earnings ratio of 17.36, a PEG ratio of 0.92 and a beta of 1.20.

Cabot (NYSE:CBT) last posted its earnings results on Monday, November 4th. The specialty chemicals company reported $1.80 EPS for the quarter, missing analysts’ consensus estimates of $1.81 by ($0.01). The business had revenue of $1 billion during the quarter, compared to analysts’ expectations of $1.01 billion. Cabot had a net margin of 9.51% and a return on equity of 27.14%. Cabot’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.65 EPS. Equities research analysts expect that Cabot will post 7.82 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently issued reports on CBT. Mizuho lifted their price objective on Cabot from $103.00 to $122.00 and gave the company an “outperform” rating in a research note on Tuesday. JPMorgan Chase & Co. boosted their price target on shares of Cabot from $95.00 to $105.00 and gave the stock a “neutral” rating in a report on Wednesday, August 7th. Finally, UBS Group reduced their price objective on shares of Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a report on Tuesday, August 6th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Cabot has an average rating of “Hold” and a consensus price target of $105.00.

Insider Buying and Selling

In other Cabot news, CFO Erica Mclaughlin sold 16,390 shares of the firm’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $104.24, for a total transaction of $1,708,493.60. Following the transaction, the chief financial officer now owns 59,814 shares of the company’s stock, valued at approximately $6,235,011.36. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, CFO Erica Mclaughlin sold 16,390 shares of the firm’s stock in a transaction that occurred on Tuesday, August 27th. The shares were sold at an average price of $104.24, for a total transaction of $1,708,493.60. Following the transaction, the chief financial officer now directly owns 59,814 shares in the company, valued at approximately $6,235,011.36. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Hobart Kalkstein sold 5,457 shares of the firm’s stock in a transaction on Tuesday, August 20th. The stock was sold at an average price of $100.58, for a total transaction of $548,865.06. Following the transaction, the executive vice president now directly owns 61,688 shares in the company, valued at $6,204,579.04. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,665 shares of company stock worth $4,986,299 in the last ninety days. 3.07% of the stock is owned by corporate insiders.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.